NCT04625166

Combi-elastography Assessment of Chronic Liver Disease Multi-center Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 880 (estimated)
• Sponsor: Chinese PLA General Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Accepted

Summary

HITACH developed a new combi-elastography imaging technology combines shear wave imaging and strain imaging technology. In the study, not only the F index which is related to the stage of liver fibrosis can be obtained, but also the A index which is related to the stage of hepatitis can be obtained, which can not be obtained by other ultrasound devices.

Detailed description

HITACHI developed a new combi-elastography imaging technology combines shear wave imaging and strain imaging technology to make full use of these two imaging modalities and make full use of different physical characteristics for imaging and quantitative analysis. In the study, not only the F index which is related to the stage of liver fibrosis can be obtained, but also the A index which is related to the stage of hepatitis can be obtained, which can not be obtained by other ultrasound devices. This technology is non-invasive, painless, simple and reliable, therefore it is bound to contribute to the early diagnosis of chronic liver disease and the real-time evaluation in the treatment process, which will play an important role in the clinical application.

Conditions

• Non Alcoholic Fatty Liver
• Hepatitis B
• Drug-induced Liver Injury

Timeline

• Start date: 2020-12-01
• Primary completion: 2022-01-01
• Completion: 2022-06-30
• First posted: 2020-11-12
• Last updated: 2021-01-12

Locations

1 site across 1 country: China